Resistance to Immunotherapeutic Antibodies in Cancer Strategies to Overcome Resistance /
The current application of antibody-meditated targeted therapy against cancer has resulted in significant objective clinical responses, prolongation of survival and even cures. More than 20 mAbs have been approved for human use targeting a range of different cancers. However, a major drawback of mAb...
Published in: | Springer eBooks |
---|---|
Corporate Author: | SpringerLink (Online service) |
Other Authors: | Bonavida, Benjamin (Editor) |
Format: | eBook |
Language: | English |
Published: |
New York, NY :
Springer New York : Imprint: Springer,
2013.
|
Series: | Resistance to Targeted Anti-Cancer Therapeutics,
|
Subjects: | |
Online Access: | http://dx.doi.org/10.1007/978-1-4614-7654-2 Перейти в каталог НБ ТГУ |
Similar Items
-
Macrophages: Biology and Role in the Pathology of Diseases
Published: (2014) -
The New Paradigm of Immunity to Tuberculosis
Published: (2013) -
IgE Antibodies: Generation and Function
Published: (2015) -
MHC Class I Antigens In Malignant Cells Immune Escape And Response To Immunotherapy /
by: Aptsiauri, Natalia, et al.
Published: (2013) -
Heat Shock Proteins in Cancer
by: Calderwood, Stuart K.
Published: (2007)